ibusinesslines.com
ibusinesslines.com May 27, 2018


Ocular Therapeutix, Inc. (NASDAQ:OCUL) Downgraded by Morgan Stanley

17 July 2017, 08:37 | Kelvin Horton

On 07/13/2017 close, Ocular Therapeutix, Inc. Morgan Stanley lowered shares of Ocular Therapeutix from an "overweight" rating to an "equal weight" rating and set a $16.00 price objective for the company.in a research note on Friday, June 23rd. American International Group Inc. now owns 11,138 shares of the biopharmaceutical company's stock worth $103,000 after buying an additional 844 shares during the last quarter.

A number of brokerages have recently weighed in on OCUL. The other 3, though not evenly; between analysts who think you should buy Ocular Therapeutix, Inc. versus those who think you should sell it. According to Thomson Reuters, sell-side analysts are forecasting a harmony target price of $27.00 on company shares. The firm has "Overweight" rating by Cantor Fitzgerald given on Friday, February 10. They now have a Dollars 21 price target on the stock. The stock experienced -4.88% slump, arriving at $6.33 on Jul. 14, 2017. In contrast, the average volume was 1.37 million shares. The stock's current distance from 20-Day Simple Moving Average (SMA20) is -30.31% where SMA50 and SMA200 are -32.26% and -22% respectively. Ocular Therapeutix has a one year low of $4.04 and a one year high of $11.91. The stock's market capitalization is $178.52 million.

Ocular Therapeutix (NASDAQ:OCUL) last released its quarterly earnings results on Friday, May 5th. The company maintains price to book ratio of 2.15 vs.an industry average at 1.27. It has a return on equity (ROE) of -80.20%. The firm had revenue of $0.48 million for the quarter, compared to the consensus estimate of $0.51 million. (OCUL) is -0.58 while the analysts predicted the EPS of the stock to be -0.48 suggesting the company fell short of the analysts' expectations. On average, equities analysts expect that Ocular Therapeutix will post ($2.25) EPS for the current fiscal year. The correct version of this article can be viewed at https://www.com-unik.info/2017/07/17/fy2017-eps-estimates-for-ocular-therapeutix-inc-lifted-by-cantor-fitzgerald-nasdaqocul.html. Cantor Fitzgerald now has a "Overweight" rating and a $21.00 target price on the stock. If you are reading this news story on another website, it was stolen and reposted in violation of global trademark & copyright laws. About shares traded. Ocular Therapeutix Inc (NASDAQ:OCUL) has declined 9.50% since July 17, 2016 and is downtrending.

Institutional investors have recently added to or reduced their stakes in the company.


ILLEGAL ACTIVITY WARNING: "49,024 Shares in Ocular Therapeutix, Inc".

A stock rating usually tells investors how well a stock's market value relates to what analysts think is a fair value for the stock, based on an independent evaluation of the company. Berson & Corrado Investment Advisors LLC increased its stake in Ocular Therapeutix by 5.8% in the first quarter. Columbus Circle Investors boosted its stake in Ocular Therapeutix by 131.4% in the first quarter. Deltec Asset Management LLC now owns 399,200 shares of the biopharmaceutical company's stock worth $3,705,000 after buying an additional 284,200 shares during the period. Finally, Trexquant Investment LP bought a new position in shares of Ocular Therapeutix during the fourth quarter valued at about $181,000.

Institutional investors now hold around $122 million or 63.9% in OCUL stock.

Taking a look back at some historical performance numbers for Ocular Therapeutix, Inc. The Firm is focused on the development and commercialization of therapies for diseases and conditions of the eye using its hydrogel platform technology.



Other News

Trending Now

Rouhani's brother arrested on financial charges: Judiciary
Also, Karan Vafadari, who owns an art gallery in Tehran , was arrested last July with his wife, who is a permanent US resident. A Chinese-born American researcher has been awarded 10 years of imprisonment after being convicted of spying in Iran .

Jackie Bradley Jr. spectacularly robbed Aaron Judge of a sure home run
Bradley stalked it toward the wall that juts out from right-center, leaped and reached over to pull the ball in. One night after giving up a tying homer in the ninth, Craig Kimbrel pitched the ninth for his 24th save.

DHS Approves 15000 Additional Temporary Worker Visas
To receive the visas, businesses must attest they would suffer irreparable harm if they can not bring in those workers. The administration insisted the visa boost is not incompatible with its "America first" pledge.

Troops On Offensive To Re-Take Helmand's Nawa District
The security forces plan to continue the operation southward along the main road to the town of Garmsir, officials said. The Afghan government said Monday that troops retook a key district in the southern Helmand province from the Taliban.

The Fairmount Santrol Holdings Target of Unusually Large Options Trading (FMSA)
The stock of Fairmount Santrol Holdings Inc (NYSE:FMSA) earned "Sector Outperform" rating by Howard Weil on Monday, December 14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link .

Cigarettes to cost more as GST Council okays higher cess rates
Jaitley said to correct this, the GST Council has raised the fixed cess by Rs 485 to 792 per thousand sticks. Also, Union Minister Jaitley confirmed that the new tax rate will be effective from midnight tonight.

Jay-Z Snags His 14th No. Album with '4:44'
The album, Jay-Z's first in four years, won favorable reviews and marked growing introspection from the 47-year-old rapper. Ever since Vol. 2.Hard Knock Life which came out in 1998, every one of Hov's solo efforts have reached the top spot.